VisasQ Inc.
Notice of Recording of Extraordinary Loss (Impairment Loss on Quarterly Capitalized Software Development Costs)
A consolidated subsidiary, Coleman Research Group, recorded an impairment loss of approximately 61 million yen on software development-related assets in the second quarter of the consolidated fiscal period. This was already factored into the previously announced earnings guidance and does not affect the current fiscal year earnings forecast. Software development expenses are expected to continue to occur going forward.
Key Figures
- Extraordinary loss: approx. 61 million yen
- Impairment recorded in 2026 Q2
- Impact on earnings forecast: Unchanged
AI要約
Recording of Extraordinary Loss and Background
The Company recorded as an impairment the portion of customer- and expert-facing software development costs incurred by consolidated subsidiary Coleman Research Group, Inc. that was determined to require capitalization under U.S. GAAP after capitalizing those costs. Approximately 61 million yen was recorded in the second quarter of the consolidated fiscal period. The impairment was already incorporated into the earnings guidance published in April 2026 and does not affect the consolidated earnings forecast for the current fiscal year. Software development expenses are expected to continue to be incurred to support business growth.
Future Impact and Policy
This impairment relates to the capitalization of specific assets and, since it was already factored into forecasts, is considered to have limited short-term financial impact. The Company intends to continue investing in software development, and this is not expected to affect its long-term growth strategy. Foreign exchange information is provided but is not included in the direct assessment of the impact of this matter.
VisasQ Inc.
Company overview · Stock price · Financial data · All IR
